Literature DB >> 26573298

The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.

Yuliya Skabytska1,2, Susanne Kaesler1,2, Thomas Volz1, Tilo Biedermann3.   

Abstract

The skin is the largest organ at the interface between the environment and the host. Consequently, the skin plays a central role in mounting effective host defense. In addition to pathogens, the microbiota and the host immune system are in permanent contact and communication via the skin. Consequences of this permanent interaction are a unique and partly symbiotic relationship, a tight interdependence between these partners, and also a functional "setting the clock," in which, in the healthy steady state, an induction of protective responses to pathogens is guaranteed. At the same time, commensal microbes contribute to the alertness of the immune system and to the maintenance of immune tolerance. Atopic dermatitis (AD) is a chronic inflammatory skin disease based on a complex genetic trait with defects in cutaneous barrier, in stabilizing skin integrity. Most of AD patients develop deviated innate and adaptive immune responses. As a result, increased susceptibility to cutaneous infection is found in AD patients, and the interactions between these microbes and the skin participate in the development of chronic cutaneous inflammation. The role of the adaptive immune system was characterized in much detail, less though the contribution of innate immunity to AD pathogenesis. It is rather recent evidence that demonstrates a dominant role of components of the innate immune system not only for protecting from microbial invasion but also by orchestrating chronic skin inflammation. In this review we discuss the role of innate immune signaling and consecutive immune networks important for the pathogenesis and management of AD.

Entities:  

Keywords:  Atopic dermatitis; Cutaneous inflammation; TLR2

Mesh:

Substances:

Year:  2015        PMID: 26573298     DOI: 10.1007/s00281-015-0544-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  129 in total

1.  Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations.

Authors:  Michael Kabesch; Wilfried Peters; David Carr; Wolfgang Leupold; Stephan K Weiland; Erika von Mutius
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

Review 2.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

3.  The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype.

Authors:  Parviz Ahmad-Nejad; Salima Mrabet-Dahbi; Kristine Breuer; Martina Klotz; Thomas Werfel; Udo Herz; Klaus Heeg; Michael Neumaier; Harald Renz
Journal:  J Allergy Clin Immunol       Date:  2004-03       Impact factor: 10.793

Review 4.  Surface protein adhesins of Staphylococcus aureus.

Authors:  T J Foster; M Höök
Journal:  Trends Microbiol       Date:  1998-12       Impact factor: 17.079

Review 5.  Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Authors:  Cezmi A Akdis; Mübeccel Akdis; Thomas Bieber; Carsten Bindslev-Jensen; Mark Boguniewicz; Philippe Eigenmann; Qutayba Hamid; Alexander Kapp; Donald Y M Leung; Jasna Lipozencic; Thomas A Luger; Antonella Muraro; Natalija Novak; Thomas A E Platts-Mills; Lanny Rosenwasser; Annika Scheynius; F Estelle R Simons; Jonathan Spergel; Kristiina Turjanmaa; Ulrich Wahn; Stefan Weidinger; Thomas Werfel; Torsten Zuberbier
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

6.  IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo.

Authors:  Rieko Kurahashi; Yutaka Hatano; Kazumoto Katagiri
Journal:  J Invest Dermatol       Date:  2007-10-25       Impact factor: 8.551

7.  Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis.

Authors:  Joohee Lee; David Seto; Leonard Bielory
Journal:  J Allergy Clin Immunol       Date:  2008-01       Impact factor: 10.793

8.  IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Authors:  Emmanuella Guenova; Yuliya Skabytska; Wolfram Hoetzenecker; Günther Weindl; Karin Sauer; Manuela Tham; Kyu-Won Kim; Ji-Hyeon Park; Ji Hae Seo; Desislava Ignatova; Antonio Cozzio; Mitchell P Levesque; Thomas Volz; Martin Köberle; Susanne Kaesler; Peter Thomas; Reinhard Mailhammer; Kamran Ghoreschi; Knut Schäkel; Boyko Amarov; Martin Eichner; Martin Schaller; Rachael A Clark; Martin Röcken; Tilo Biedermann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 9.  Innate immune defense system of the skin.

Authors:  Maryam Afshar; Richard L Gallo
Journal:  Vet Dermatol       Date:  2013-02       Impact factor: 1.589

Review 10.  TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity.

Authors:  Ulrich Zähringer; Buko Lindner; Seiichi Inamura; Holger Heine; Christian Alexander
Journal:  Immunobiology       Date:  2008-03-28       Impact factor: 3.144

View more
  8 in total

1.  A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.

Authors:  ZhaoFei Wang; LiCheng Kong; Yang Liu; Qiang Fu; ZeLin Cui; Jian Wang; JingJiao Ma; HengAn Wang; YaXian Yan; JianHe Sun
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

Review 2.  Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics.

Authors:  Shawn G Kwatra; Laurent Misery; Claire Clibborn; Martin Steinhoff
Journal:  Clin Transl Immunology       Date:  2022-05-09

Review 3.  The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.

Authors:  Pawinee Rerknimitr; Atsushi Otsuka; Chisa Nakashima; Kenji Kabashima
Journal:  Inflamm Regen       Date:  2017-06-05

4.  Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis.

Authors:  Joanna Salomon; Łukasz Matusiak; Danuta Nowicka-Suszko; Jacek C Szepietowski
Journal:  J Immunol Res       Date:  2017-06-04       Impact factor: 4.818

Review 5.  Skin barrier in atopic dermatitis: beyond filaggrin.

Authors:  Mariana Colombini Zaniboni; Luciana Paula Samorano; Raquel Leão Orfali; Valéria Aoki
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

Review 6.  Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.

Authors:  Olabola Awosika; Lori Kim; Momina Mazhar; Monica Rengifo-Pardo; Alison Ehrlich
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-01-24

Review 7.  Immune response patterns in non-communicable inflammatory skin diseases.

Authors:  K Eyerich; S Eyerich
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-15       Impact factor: 6.166

8.  Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone.

Authors:  Katia Mangano; Franca Vergalito; Santa Mammana; Andrea Mariano; Rocco De Pasquale; Antonia Meloscia; Silvia Bartollino; Germano Guerra; Ferdinando Nicoletti; Roberto Di Marco
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.